sera – Page 41 – Communicable Diseases Research

Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients

BNT162B2 백신 수용자로부터 혈청에 의한 SARS-COV-2 변이체의 중화

Article

Published on 2021-10-062022-09-01
Journal: Viruses [Category] MERS, SARS, 변종, 진단,

A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array

6-플렉스 항원 어레이에 의한 이스라엘의 COVID-19 초기 단계의 혈청학적 스냅샷

Research Article

Published on 2021-10-062022-09-10
Journal: Microbiology Spectrum [Category] MERS, SARS, 진단, 치료법,

[키워드] Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Antigen applied characterization collected COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 patient COVID-19 patients cross-reacting antibodies death ectodomain evaluate FIVE generate healthy healthy subject IgA antibodies IgA antibody IgG IgM immune response immune responses inactivated individual individuals Israel Microarray Microarrays multiplex naïve individuals nonspecific NTD nucleocapsid outbreak pandemic Patient patients PCR presenting Protein qRT-PCR quantitative PCR RBD resulting reverse transcription SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 seroprevalence SARS-CoV-2-specific IgG screened sensitivity sera Seroconversion serological serological marker serology Specific specific IgM specificity spike Stage subunit symptom onset symptomatic trials Vaccine Viral Viral antigen viral antigens virus was used
[DOI] 10.1128/Spectrum.00870-21 PMC 바로가기 [Article Type] Research Article

Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation

Article

Published on 2021-10-062022-10-31
Journal: Diagnostics [Category] COVID-19,

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

수용체 결합 도메인과 N-말단 도메인 중화 항체의 조합은 SARS-CoV-2 스파이크 중화-도피 돌연변이의 생성을 제한합니다

Research Article

Published on 2021-10-052022-09-10
Journal: mBio [Category] MERS, SARS, 변종, 진단,

[키워드] analyzed antibody approved binding characterized Combination COVID-19 COVID-19 convalescent donor COVID-19 convalescent donors defined Effectiveness Efficacy Emergency use ENhance epitope Epitopes escape mutants FDA Generation hACE2 in vitro include inhibit less memory B-cell MOST mutant Mutation N-terminal domain NAb NAbs neutralization Neutralization assay neutralization assays neutralization potency NTD Protein RBD RBD-targeting nAbs Receptor-binding domain reduce reduced Region residue S protein SARS-CoV-2 SARS-CoV-2 neutralizing antibodies SARS-CoV-2 neutralizing antibody SARS-CoV-2 S protein SARS2 sera spike spike mutations stomatitis susceptible the RBD the receptor-binding domain therapy utility Vaccine variants variants of concern vesicular stomatitis vesicular stomatitis virus Viral viral infection VoC yeast
[DOI] 10.1128/mBio.02473-21 PMC 바로가기 [Article Type] Research Article

A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW)

Article

Published on 2021-10-052022-10-31
Journal: Diagnostics [Category] COVID-19,

Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity

Research article

Published on 2021-10-042022-10-05
Journal: Cell Host & Microbe [Category] 비임상,

Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy

임신 중 산모의 SARS-CoV-2 불활성 백신(CoronaVac) 투여 후 제대혈 항체

Article

Published on 2021-10-032022-09-11
Journal: Human vaccines & immunotherapeutics [Category] SARS, 치료기술,

[키워드] administration adverse event adverse events age anti-RBD anti-receptor-binding domain antibodies antibody arbitrary unit Beijing Birth Birth weight Blood Care China Cord blood CoronaVac detectable Efficacy first dose first identified case gestation gestational age HCW Health Health care healthy IgG antibodies inactivated inactive life Maternal mother Newborn placental Pregnancy RBD reported SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 vaccines Science second dose sera Sinovac Spike protein the vaccine transfer vaccination Vaccine virus
[DOI] 10.1080/21645515.2021.1947099 PMC 바로가기 [Article Type] Article

Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers

Brief Report

Published on 2021-10-032022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] age analyzed antibody Antibody Response Antigen asked baseline BMI BNT162b2 carried chemiluminescent immunoassay collected Comorbidity correlation COVID-19 COVID-19 negative COVID-19 pandemic decrease demonstrated dose first dose Gender geometric mean concentration greater HCW Health care worker highest IgG antibody immune response immunogenicity data median men Month mRNA vaccine National of BNT162b2 other variable participant persistence positive positive individual reached S1/S2 SARS-CoV-2 SARS-COV-2 infection second vaccination sera serum sample significant increase supported the vaccine turn Vaccine was performed women worker
[DOI] 10.3390/vaccines9101125 PMC 바로가기 [Article Type] Brief Report

Weak Cross-Lineage Neutralization by Anti SARS-CoV-2 Spike Antibodies after Natural Infection or Vaccination Is Rescued by Repeated Immunological Stimulation

Article

Published on 2021-10-022022-10-28
Journal: Vaccines [Category] COVID-19,

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection

SARS-CoV-2 감염 후 뉴클레오캡시드 및 스파이크 단백질에 대한 IgG 항체 반응

Observational Study

Published on 2021-10-012022-09-11
Journal: Infection [Category] MERS, SARS, 임상, 진단, 치료법,

[키워드] Abbott antibody Architect Chain Reaction changes in collected Complete Concentration coronavirus coronavirus disease Coronavirus disease-19 COVID-19 enrolment epidemiological Follow-up Frequency growth help IgG IgG antibody individual Infection magnitude neutralising nucleocapsid nucleocapsid antigen nucleocapsid protein Observational cohort study pandemic persistence platform polymerase chain reaction positive Protein public health quantitative assay real-time reverse transcriptase-polymerase chain reaction recorded remained reverse transcriptase reverse transcriptase-polymerase chain reaction Roche RT-qPCR SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sera seronegative seropositive serum sample serum samples spike Spike protein tested titre virus
[DOI] 10.1007/s15010-021-01651-4 PMC 바로가기 [Article Type] Observational Study